ORBIMED ADVISORS LLC - Dec 31, 2024 SCHEDULE 13G Report for RAPT Therapeutics, Inc. Common Stock, par value $0.0001 per share (RAPT)

Filing Manager: ORBIMED ADVISORS LLC
Reporting Manager: ORBIMED ADVISORS LLC
Security: RAPT Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: RAPT
Shares outstanding: 133M shares
Disclosed Ownership: 13.1M shares
Ownership: 9.9%
Form type: SCHEDULE 13G
Date filed: 2/14/2025, 04:32 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
ORBIMED ADVISORS LLC	9.9%	13.1M	0	13.1M	/s/ Carl L. Gordon	Carl L. Gordon/Member

Showing 1 to 1 of 1 entries